(-)-alpha-phellandrene increases expression ISO RGD:736916 6480464 alpha phellandrene results in increased expression of GNAS mRNA CTD PMID:25075043 (1->4)-beta-D-glucan multiple interactions EXP 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of GNAS mRNA CTD PMID:36331819 (R)-noradrenaline multiple interactions ISO RGD:736916 6480464 Norepinephrine promotes the reaction [ADRB1 protein results in increased activity of GNAS protein] CTD PMID:17200720 1,2-dichloroethane increases expression EXP 6480464 ethylene dichloride results in increased expression of GNAS mRNA CTD PMID:28960355 1,2-dimethylhydrazine multiple interactions EXP 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of GNAS mRNA CTD PMID:22206623 1,2-dimethylhydrazine affects expression EXP 6480464 1, 2-Dimethylhydrazine affects the expression of GNAS mRNA CTD PMID:22206623 1,2-dimethylhydrazine increases expression EXP 6480464 1, 2-Dimethylhydrazine results in increased expression of GNAS mRNA CTD PMID:22206623 17beta-estradiol multiple interactions ISO RGD:736916 6480464 3 more ... CTD PMID:11179685 17beta-estradiol decreases expression EXP 6480464 Estradiol results in decreased expression of GNAS mRNA CTD PMID:30077407 17beta-estradiol multiple interactions EXP 6480464 [Polyphenols co-treated with Estradiol] results in decreased expression of GNAS mRNA CTD PMID:30077407 17beta-estradiol decreases expression ISO RGD:736916 6480464 Estradiol results in decreased expression of GNAS mRNA CTD PMID:11179685 2,2',4,4'-Tetrabromodiphenyl ether affects expression EXP 6480464 2 more ... CTD PMID:30294300 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:736916 6480464 Tetrachlorodibenzodioxin inhibits the reaction [Estradiol results in decreased expression of GNAS mRNA] CTD PMID:11179685 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of GNAS mRNA CTD PMID:21570461 , PMID:26377647 2,3,7,8-Tetrachlorodibenzofuran increases expression ISO RGD:2716 6480464 2 more ... CTD PMID:32109520 3',5'-cyclic AMP multiple interactions ISO RGD:736916 6480464 [[GNAS protein results in increased susceptibility to citronellal] which results in increased activity of OR6E1 protein] which results in increased abundance of Cyclic AMP, GNAS protein promotes the reaction [[cicaprost results in increased activity of PTGIR protein] which results in increased abundance of Cyclic AMP] CTD PMID:11895442 , PMID:15598656 3',5'-cyclic AMP multiple interactions EXP 6480464 [[6alpha-ethyl-23(S)-methylcholic acid binds to and results in increased activity of GPBAR1 protein] which results in increased activity of GNAS protein] which results in increased abundance of Cyclic AMP, [[Oleanolic Acid binds to and results in increased activity of GPBAR1 protein] which results in increased activity of GNAS protein] which results in increased abundance of Cyclic AMP CTD PMID:23022524 3,3'-diindolylmethane multiple interactions ISO RGD:736916 6480464 3, 3'-diindolylmethane inhibits the reaction [Estradiol results in decreased expression of GNAS mRNA] CTD PMID:11179685 4,4'-sulfonyldiphenol decreases methylation EXP 6480464 bis(4-hydroxyphenyl)sulfone results in decreased methylation of GNAS exon CTD PMID:33297965 4,4'-sulfonyldiphenol multiple interactions ISO RGD:2716 6480464 [bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of GNAS mRNA CTD PMID:36041667 4,4'-sulfonyldiphenol increases expression ISO RGD:736916 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of GNAS protein CTD PMID:34186270 4,4'-sulfonyldiphenol affects methylation EXP 6480464 bis(4-hydroxyphenyl)sulfone affects the methylation of GNAS gene, bis(4-hydroxyphenyl)sulfone affects the methylation of GNAS promoter CTD PMID:31683443 , PMID:33297965 4-hydroxynon-2-enal decreases expression ISO RGD:736916 6480464 4-hydroxy-2-nonenal results in decreased expression of GNAS mRNA CTD PMID:12419474 5-(hydroxymethyl)cytosine multiple interactions EXP 6480464 [bisphenol A results in increased methylation of GNAS intron] which results in increased abundance of 5-hydroxymethylcytosine CTD PMID:30044229 6-propyl-2-thiouracil increases expression ISO RGD:2716 6480464 Propylthiouracil results in increased expression of GNAS mRNA CTD PMID:24780913 acrolein multiple interactions ISO RGD:736916 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of GNAS mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of GNAS mRNA CTD PMID:32699268 aflatoxin B1 decreases methylation ISO RGD:736916 6480464 Aflatoxin B1 results in decreased methylation of GNAS gene CTD PMID:27153756 all-trans-retinoic acid decreases expression ISO RGD:736916 6480464 Tretinoin results in decreased expression of GNAS mRNA CTD PMID:21934132 alpha-phellandrene increases expression ISO RGD:736916 6480464 alpha phellandrene results in increased expression of GNAS mRNA CTD PMID:25075043 alpha-pinene multiple interactions ISO RGD:736916 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of GNAS mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of GNAS mRNA CTD PMID:32699268 alprenolol multiple interactions ISO RGD:736916 6480464 [Alprenolol co-treated with ADRB2 protein] results in increased expression of GNAS protein CTD PMID:10455254 amiodarone increases expression ISO RGD:736916 6480464 Amiodarone results in increased expression of GNAS mRNA CTD PMID:19774075 ammonium chloride affects expression ISO RGD:2716 6480464 Ammonium Chloride affects the expression of GNAS mRNA CTD PMID:16483693 antirheumatic drug increases expression ISO RGD:736916 6480464 Antirheumatic Agents results in increased expression of GNAS mRNA CTD PMID:24449571 Aroclor 1254 decreases expression EXP 6480464 Chlorodiphenyl (54% Chlorine) results in decreased expression of GNAS mRNA CTD PMID:23650126 arsenite(3-) affects methylation ISO RGD:736916 6480464 arsenite affects the methylation of GNAS promoter CTD PMID:23974009 bathocuproine disulfonic acid multiple interactions ISO RGD:736916 6480464 [pyrrolidine dithiocarbamic acid co-treated with bathocuproine sulfonate] results in increased expression of GNAS mRNA CTD PMID:15477007 benzene decreases expression ISO RGD:736916 6480464 Benzene results in decreased expression of GNAS mRNA CTD PMID:33064461 benzo[a]pyrene affects methylation ISO RGD:736916 6480464 Benzo(a)pyrene affects the methylation of GNAS 3' UTR, Benzo(a)pyrene affects the methylation of GNAS 5' UTR CTD PMID:27901495 benzo[a]pyrene increases methylation ISO RGD:736916 6480464 Benzo(a)pyrene results in increased methylation of GNAS exon, Benzo(a)pyrene results in increased methylation of GNAS promoter CTD PMID:27901495 bis(2-ethylhexyl) phthalate affects expression EXP 6480464 Diethylhexyl Phthalate affects the expression of GNAS mRNA CTD PMID:21636974 bisoprolol increases expression ISO RGD:2716 6480464 Bisoprolol results in increased expression of GNAS mRNA CTD PMID:20668454 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of GNAS mRNA CTD PMID:21636974 bisphenol A multiple interactions ISO RGD:2716 6480464 [bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of GNAS mRNA CTD PMID:36041667 bisphenol A multiple interactions ISO RGD:736916 6480464 [bisphenol A co-treated with Fulvestrant] results in decreased methylation of GNAS gene CTD PMID:31601247 bisphenol A affects methylation EXP 6480464 bisphenol A affects the methylation of GNAS intron CTD PMID:30044229 , PMID:30073950 bisphenol A multiple interactions EXP 6480464 [bisphenol A results in increased methylation of GNAS intron] which results in increased abundance of 5-hydroxymethylcytosine CTD PMID:30044229 bisphenol A affects expression ISO RGD:736916 6480464 bisphenol A affects the expression of GNAS mRNA CTD PMID:30903817 bisphenol A increases expression ISO RGD:736916 6480464 bisphenol A results in increased expression of GNAS mRNA, bisphenol A results in increased expression of GNAS protein CTD PMID:29275510 , PMID:34186270 bisphenol A decreases methylation EXP 6480464 bisphenol A results in decreased methylation of GNAS 5' UTR more ... CTD PMID:27312807 more ... bisphenol A increases methylation ISO RGD:2716 6480464 bisphenol A results in increased methylation of GNAS gene CTD PMID:28505145 bisphenol A increases methylation EXP 6480464 bisphenol A results in increased methylation of GNAS promoter CTD PMID:27312807 bisphenol A decreases methylation ISO RGD:736916 6480464 bisphenol A results in decreased methylation of GNAS gene, bisphenol A results in decreased methylation of GNAS promoter CTD PMID:27271280 , PMID:31601247 bisphenol A increases expression ISO RGD:2716 6480464 bisphenol A results in increased expression of GNAS mRNA CTD PMID:25181051 more ... bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of GNAS mRNA CTD PMID:26063408 more ... Bisphenol B increases expression ISO RGD:736916 6480464 bisphenol B results in increased expression of GNAS protein CTD PMID:34186270 bisphenol F increases expression ISO RGD:736916 6480464 bisphenol F results in increased expression of GNAS protein CTD PMID:34186270 bisphenol F multiple interactions ISO RGD:2716 6480464 [bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of GNAS mRNA CTD PMID:36041667 butanal decreases expression ISO RGD:736916 6480464 butyraldehyde results in decreased expression of GNAS mRNA CTD PMID:26079696 caffeine decreases expression ISO RGD:2716 6480464 Caffeine results in decreased expression of GNAS protein CTD PMID:15708489 calcium atom multiple interactions EXP 6480464 [[6alpha-ethyl-23(S)-methylcholic acid binds to and results in increased activity of GPBAR1 protein] which results in increased activity of GNAS protein] which results in increased abundance of Calcium, [[Oleanolic Acid binds to and results in increased activity of GPBAR1 protein] which results in increased activity of GNAS protein] which results in increased abundance of Calcium CTD PMID:23022524 calcium(0) multiple interactions EXP 6480464 [[6alpha-ethyl-23(S)-methylcholic acid binds to and results in increased activity of GPBAR1 protein] which results in increased activity of GNAS protein] which results in increased abundance of Calcium, [[Oleanolic Acid binds to and results in increased activity of GPBAR1 protein] which results in increased activity of GNAS protein] which results in increased abundance of Calcium CTD PMID:23022524 carbamazepine affects expression ISO RGD:736916 6480464 Carbamazepine affects the expression of GNAS mRNA CTD PMID:24752500 carbon nanotube increases expression EXP 6480464 Nanotubes, Carbon results in increased expression of GNAS mRNA CTD PMID:25620056 carvedilol multiple interactions ISO RGD:736916 6480464 [carvedilol co-treated with ADRB2 protein] results in increased expression of GNAS protein CTD PMID:10455254 carvedilol increases expression ISO RGD:2716 6480464 carvedilol results in increased expression of GNAS mRNA CTD PMID:20668454 CGP 52608 multiple interactions ISO RGD:736916 6480464 CGP 52608 promotes the reaction [RORA protein binds to GNAS gene] CTD PMID:28238834 chloropicrin decreases expression ISO RGD:736916 6480464 chloropicrin results in decreased expression of GNAS mRNA CTD PMID:26352163 chloroprene increases expression ISO RGD:2716 6480464 Chloroprene results in increased expression of GNAS mRNA CTD PMID:23125180 chlorpyrifos increases expression EXP 6480464 Chlorpyrifos results in increased expression of GNAS mRNA CTD PMID:37019170 cholesterol multiple interactions ISO RGD:736916 6480464 Cholesterol inhibits the reaction [Progesterone results in increased expression of GNAS protein] CTD PMID:19221014 cicaprost multiple interactions ISO RGD:736916 6480464 cicaprost promotes the reaction [PTGIR protein binds to GNAS protein], GNAS protein promotes the reaction [[cicaprost results in increased activity of PTGIR protein] which results in increased abundance of Cyclic AMP] CTD PMID:11895442 cisplatin multiple interactions ISO RGD:736916 6480464 [GNAS protein results in increased expression of XIAP protein] which results in decreased susceptibility to Cisplatin more ... CTD PMID:21255191 cisplatin decreases response to substance ISO RGD:736916 6480464 GNAS results in decreased susceptibility to Cisplatin CTD PMID:21849418 citronellal increases response to substance ISO RGD:736916 6480464 GNAS protein results in increased susceptibility to citronellal CTD PMID:15598656 citronellal multiple interactions ISO RGD:736916 6480464 [[GNAS protein results in increased susceptibility to citronellal] which results in increased activity of OR6E1 protein] which results in increased abundance of Cyclic AMP more ... CTD PMID:15598656 clozapine decreases expression ISO RGD:2716 6480464 Clozapine results in decreased expression of GNAS mRNA CTD PMID:15860345 clozapine increases expression ISO RGD:736916 6480464 Clozapine results in increased expression of GNAS protein CTD PMID:34122009 clozapine multiple interactions ISO RGD:736916 6480464 [Cuprizone co-treated with Clozapine] results in decreased expression of GNAS protein CTD PMID:34122009 cobalt dichloride decreases expression ISO RGD:736916 6480464 cobaltous chloride results in decreased expression of GNAS mRNA CTD PMID:19320972 copper(II) sulfate decreases activity ISO RGD:2716 6480464 Copper Sulfate results in decreased activity of GNAS protein CTD PMID:15546818 Cuprizon multiple interactions ISO RGD:736916 6480464 [Cuprizone co-treated with Clozapine] results in decreased expression of GNAS protein CTD PMID:34122009 cyclosporin A decreases methylation ISO RGD:736916 6480464 Cyclosporine results in decreased methylation of GNAS promoter CTD PMID:27989131 dexamethasone increases expression ISO RGD:2716 6480464 Dexamethasone results in increased expression of GNAS mRNA CTD PMID:7730645 dibutyl phthalate decreases expression ISO RGD:2716 6480464 Dibutyl Phthalate results in decreased expression of GNAS mRNA CTD PMID:21266533 dichlorine multiple interactions ISO RGD:2716 6480464 [Ozone co-treated with Chlorine] results in decreased expression of GNAS mRNA CTD PMID:18636392 diclofenac affects expression ISO RGD:736916 6480464 Diclofenac affects the expression of GNAS mRNA CTD PMID:24752500 dioxygen decreases expression ISO RGD:2716 6480464 Oxygen deficiency results in decreased expression of GNAS protein CTD PMID:10192281 dioxygen increases expression ISO RGD:736916 6480464 Oxygen deficiency results in increased expression of GNAS mRNA CTD PMID:20862257 dobutamine increases response to substance ISO RGD:736916 6480464 GNAS gene SNP results in increased susceptibility to Dobutamine CTD PMID:19542315 dorsomorphin multiple interactions ISO RGD:736916 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin multiple interactions ISO RGD:736916 6480464 [GNAS protein results in increased expression of XIAP protein] which results in decreased susceptibility to Doxorubicin CTD PMID:21255191 doxorubicin affects expression ISO RGD:736916 6480464 Doxorubicin affects the expression of GNAS protein CTD PMID:29385562 doxorubicin decreases expression ISO RGD:2716 6480464 Doxorubicin results in decreased expression of GNAS mRNA CTD PMID:15353854 elemental selenium multiple interactions ISO RGD:736916 6480464 [Selenium co-treated with Vitamin E] results in decreased expression of GNAS mRNA CTD PMID:19244175 elemental selenium decreases expression ISO RGD:736916 6480464 Selenium results in decreased expression of GNAS mRNA CTD PMID:19244175 Enterolactone decreases expression ISO RGD:736916 6480464 2, 3-bis(3'-hydroxybenzyl)butyrolactone results in decreased expression of GNAS mRNA CTD PMID:19167446 entinostat increases expression ISO RGD:736916 6480464 entinostat results in increased expression of GNAS mRNA CTD PMID:26272509 entinostat multiple interactions ISO RGD:736916 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GNAS mRNA CTD PMID:27188386 epoxiconazole decreases expression EXP 6480464 epoxiconazole results in decreased expression of GNAS mRNA CTD PMID:35436446 ethyl methanesulfonate decreases expression ISO RGD:736916 6480464 Ethyl Methanesulfonate results in decreased expression of GNAS mRNA CTD PMID:23649840 ethylene glycol bis(2-aminoethyl)tetraacetic acid multiple interactions ISO RGD:736916 6480464 Egtazic Acid inhibits the reaction [[GNAS protein results in increased susceptibility to citronellal] which results in increased activity of OR6E1 protein] more ... CTD PMID:15598656 finasteride increases expression ISO RGD:2716 6480464 Finasteride results in increased expression of GNAS mRNA CTD PMID:24136188 flavonoids decreases expression ISO RGD:2716 6480464 Flavonoids results in decreased expression of GNAS mRNA CTD PMID:18035473 fluoxetine increases expression ISO RGD:2716 6480464 Fluoxetine results in increased expression of GNAS mRNA CTD PMID:21852994 fluoxetine decreases expression ISO RGD:2716 6480464 Fluoxetine results in decreased expression of GNAS mRNA CTD PMID:1426031 folic acid multiple interactions EXP 6480464 [1 more ... CTD PMID:22206623 , PMID:22959928 fulvestrant multiple interactions ISO RGD:736916 6480464 [bisphenol A co-treated with Fulvestrant] results in decreased methylation of GNAS gene CTD PMID:31601247 fumonisin B1 increases expression EXP 6480464 fumonisin B1 results in increased expression of GNAS mRNA CTD PMID:16221962 genistein multiple interactions ISO RGD:2716 6480464 [Genistein co-treated with Methoxychlor] results in increased expression of GNAS mRNA CTD PMID:21782745 genistein decreases expression EXP 6480464 Genistein results in decreased expression of GNAS mRNA CTD PMID:32186404 guanosine 5'-[gamma-thio]triphosphate affects binding EXP 6480464 GNAS protein binds to Guanosine 5'-O-(3-Thiotriphosphate) CTD PMID:29748632 haloperidol decreases expression ISO RGD:2716 6480464 Haloperidol results in decreased expression of GNAS mRNA CTD PMID:15860345 hydrogen peroxide decreases expression ISO RGD:736916 6480464 Hydrogen Peroxide results in decreased expression of GNAS mRNA CTD PMID:12419474 hydrogen peroxide decreases secretion EXP 6480464 Hydrogen Peroxide results in decreased secretion of GNAS mRNA CTD PMID:21179422 ICI 118551 multiple interactions ISO RGD:736916 6480464 [ICI 118551 co-treated with ADRB2 protein] results in increased expression of GNAS protein CTD PMID:10455254 ICI 118551 increases expression EXP 6480464 ICI 118551 results in increased expression of GNAS protein CTD PMID:10455254 indometacin decreases expression ISO RGD:2716 6480464 Indomethacin results in decreased expression of GNAS protein CTD PMID:15579502 isoprenaline multiple interactions ISO RGD:2716 6480464 GNAS protein affects the susceptibility to [Potassium Chloride co-treated with Isoproterenol], Isoproterenol affects the expression of and affects the localization of GNAS protein CTD PMID:10696522 , PMID:12376418 isoprenaline multiple interactions ISO RGD:736916 6480464 Egtazic Acid inhibits the reaction [GNAS protein results in increased susceptibility to Isoproterenol] CTD PMID:15598656 isoprenaline increases response to substance ISO RGD:736916 6480464 GNAS protein results in increased susceptibility to Isoproterenol CTD PMID:15598656 ivermectin decreases expression ISO RGD:736916 6480464 Ivermectin results in decreased expression of GNAS protein CTD PMID:32959892 lead(0) increases expression ISO RGD:736916 6480464 Lead results in increased expression of GNAS mRNA CTD PMID:19921347 lead(0) affects expression ISO RGD:736916 6480464 Lead affects the expression of GNAS mRNA CTD PMID:28903495 lead(0) affects splicing ISO RGD:736916 6480464 Lead affects the splicing of GNAS mRNA CTD PMID:28903495 lipopolysaccharide multiple interactions ISO RGD:736916 6480464 [NAT10 protein affects the susceptibility to Lipopolysaccharides] which affects the expression of GNAS mRNA CTD PMID:35877022 mercury dibromide increases expression ISO RGD:736916 6480464 mercuric bromide results in increased expression of GNAS mRNA CTD PMID:26272509 methoxychlor multiple interactions ISO RGD:2716 6480464 [Genistein co-treated with Methoxychlor] results in increased expression of GNAS mRNA CTD PMID:21782745 methoxychlor increases expression ISO RGD:2716 6480464 Methoxychlor results in increased expression of GNAS mRNA CTD PMID:21782745 methoxychlor decreases expression ISO RGD:2716 6480464 Methoxychlor results in decreased expression of GNAS mRNA CTD PMID:23303685 methylmercury chloride increases expression ISO RGD:736916 6480464 methylmercuric chloride results in increased expression of GNAS mRNA CTD PMID:28001369 morphine increases expression ISO RGD:2716 6480464 Morphine results in increased expression of GNAS mRNA, Morphine results in increased expression of GNAS protein CTD PMID:17893922 N-ethyl-N-nitrosourea increases mutagenesis EXP 6480464 Ethylnitrosourea results in increased mutagenesis of GNAS gene CTD PMID:16724327 nefazodone decreases expression ISO RGD:2716 6480464 nefazodone results in decreased expression of GNAS mRNA CTD PMID:24136188 nimesulide decreases expression ISO RGD:2716 6480464 nimesulide results in decreased expression of GNAS mRNA CTD PMID:24136188 Nor-9-carboxy-delta9-THC multiple interactions ISO RGD:736916 6480464 [Cannabinoids results in increased abundance of 11-nor-delta(9)-tetrahydrocannabinol-9-carboxylic acid] which affects the methylation of GNAS gene CTD PMID:30521419 oleanolic acid multiple interactions EXP 6480464 1-(6-((3-methoxyestra-1 more ... CTD PMID:23022524 ozone multiple interactions ISO RGD:2716 6480464 [Ozone co-treated with Chlorine] results in decreased expression of GNAS mRNA CTD PMID:18636392 ozone multiple interactions EXP 6480464 [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of GNAS mRNA CTD PMID:27106289 ozone decreases expression ISO RGD:2716 6480464 Ozone results in decreased expression of GNAS protein CTD PMID:33146391 ozone multiple interactions ISO RGD:736916 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of GNAS mRNA more ... CTD PMID:32699268 ozone decreases expression EXP 6480464 Ozone results in decreased expression of GNAS mRNA CTD PMID:24336422 panobinostat multiple interactions ISO RGD:736916 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GNAS mRNA CTD PMID:27188386 panobinostat increases expression ISO RGD:736916 6480464 panobinostat results in increased expression of GNAS mRNA CTD PMID:26272509 paracetamol decreases expression ISO RGD:2716 6480464 Acetaminophen results in decreased expression of GNAS mRNA CTD PMID:33387578 paraquat increases expression EXP 6480464 Paraquat results in increased expression of GNAS mRNA CTD PMID:16797015 paraquat affects expression ISO RGD:2716 6480464 Paraquat affects the expression of GNAS mRNA CTD PMID:15206577 PCB138 decreases expression ISO RGD:2716 6480464 2 more ... CTD PMID:23829299 pentobarbital affects expression ISO RGD:2716 6480464 Pentobarbital affects the expression of GNAS mRNA CTD PMID:12199159 perfluorooctane-1-sulfonic acid multiple interactions EXP 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of GNAS mRNA CTD PMID:36331819 perfluorooctanoic acid increases expression ISO RGD:2716 6480464 perfluorooctanoic acid results in increased expression of GNAS protein CTD PMID:34958885 phencyclidine increases expression EXP 6480464 Phencyclidine results in increased expression of GNAS mRNA CTD PMID:12105081 phenobarbital increases expression ISO RGD:2716 6480464 Phenobarbital results in increased expression of GNAS mRNA CTD PMID:12082028 phenylephrine affects response to substance ISO RGD:2716 6480464 GNAS protein affects the susceptibility to Phenylephrine CTD PMID:10696522 phenylmercury acetate affects expression ISO RGD:736916 6480464 Phenylmercuric Acetate affects the expression of GNAS mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:736916 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GNAS mRNA CTD PMID:27188386 pirinixic acid increases expression ISO RGD:2716 6480464 pirinixic acid results in increased expression of GNAS mRNA CTD PMID:16940010 pirinixic acid increases expression EXP 6480464 pirinixic acid results in increased expression of GNAS mRNA CTD PMID:16221962 more ... potassium chloride multiple interactions ISO RGD:2716 6480464 GNAS protein affects the susceptibility to [Potassium Chloride co-treated with Isoproterenol] CTD PMID:10696522 pregnenolone 16alpha-carbonitrile increases expression EXP 6480464 Pregnenolone Carbonitrile results in increased expression of GNAS mRNA CTD PMID:22698814 progesterone increases expression ISO RGD:2716 6480464 Progesterone results in increased expression of GNAS protein CTD PMID:15469997 progesterone increases expression ISO RGD:736916 6480464 Progesterone results in increased expression of GNAS protein CTD PMID:19221014 progesterone multiple interactions ISO RGD:736916 6480464 CAV3 mutant form inhibits the reaction [Progesterone results in increased expression of GNAS protein], Cholesterol inhibits the reaction [Progesterone results in increased expression of GNAS protein] CTD PMID:19221014 propranolol increases expression ISO RGD:2716 6480464 Propranolol results in increased expression of GNAS mRNA CTD PMID:20668454 propranolol multiple interactions ISO RGD:736916 6480464 [Propranolol co-treated with ADRB2 protein] results in increased expression of GNAS protein CTD PMID:10455254 pyrrolidine dithiocarbamate multiple interactions ISO RGD:736916 6480464 [pyrrolidine dithiocarbamic acid co-treated with bathocuproine sulfonate] results in increased expression of GNAS mRNA CTD PMID:15477007 reserpine increases expression ISO RGD:2716 6480464 Reserpine results in increased expression of GNAS mRNA, Reserpine results in increased expression of GNAS protein CTD PMID:11264240 , PMID:8419537 reserpine decreases expression ISO RGD:2716 6480464 Reserpine results in decreased expression of GNAS protein alternative form CTD PMID:1336118 resveratrol decreases expression EXP 6480464 resveratrol results in decreased expression of GNAS mRNA CTD PMID:22610192 sarin decreases expression ISO RGD:736916 6480464 Sarin results in decreased expression of GNAS mRNA CTD PMID:19522546 SB 431542 multiple interactions ISO RGD:736916 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 selenium atom multiple interactions ISO RGD:736916 6480464 [Selenium co-treated with Vitamin E] results in decreased expression of GNAS mRNA CTD PMID:19244175 selenium atom decreases expression ISO RGD:736916 6480464 Selenium results in decreased expression of GNAS mRNA CTD PMID:19244175 silicon dioxide increases expression ISO RGD:2716 6480464 Silicon Dioxide results in increased expression of GNAS mRNA CTD PMID:18685790 sodium arsenite multiple interactions EXP 6480464 [Folic Acid co-treated with sodium arsenite] results in increased methylation of GNAS mRNA CTD PMID:22959928 sodium arsenite decreases expression ISO RGD:736916 6480464 sodium arsenite results in decreased expression of GNAS mRNA CTD PMID:29301061 Soman increases expression ISO RGD:2716 6480464 Soman results in increased expression of GNAS mRNA CTD PMID:19281266 sulindac increases expression ISO RGD:2716 6480464 Sulindac results in increased expression of GNAS mRNA CTD PMID:24136188 sunitinib increases expression ISO RGD:736916 6480464 Sunitinib results in increased expression of GNAS mRNA CTD PMID:31533062 terbutaline increases localization ISO RGD:2716 6480464 Terbutaline results in increased localization of GNAS protein alternative form CTD PMID:12376418 terbutaline affects localization ISO RGD:2716 6480464 Terbutaline affects the localization of GNAS protein CTD PMID:12376418 tert-butyl hydroperoxide decreases expression ISO RGD:736916 6480464 tert-Butylhydroperoxide results in decreased expression of GNAS mRNA CTD PMID:12419474 thapsigargin increases expression ISO RGD:2716 6480464 Thapsigargin results in increased expression of GNAS protein CTD PMID:35544339 theophylline decreases expression ISO RGD:2716 6480464 Theophylline results in decreased expression of GNAS protein CTD PMID:15708489 thioacetamide increases expression ISO RGD:2716 6480464 Thioacetamide results in increased expression of GNAS mRNA CTD PMID:34492290 titanium dioxide decreases expression EXP 6480464 titanium dioxide results in decreased expression of GNAS mRNA CTD PMID:23557971 tremolite asbestos increases expression EXP 6480464 tremolite results in increased expression of GNAS mRNA CTD PMID:29279043 trichloroethene multiple interactions EXP 6480464 PPARA protein inhibits the reaction [Trichloroethylene results in decreased expression of GNAS mRNA] CTD PMID:15363585 trichloroethene decreases expression ISO RGD:2716 6480464 Trichloroethylene results in decreased expression of GNAS mRNA CTD PMID:33387578 trichostatin A increases expression ISO RGD:736916 6480464 trichostatin A results in increased expression of GNAS mRNA CTD PMID:24935251 , PMID:26272509 trichostatin A multiple interactions ISO RGD:736916 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GNAS mRNA CTD PMID:27188386 triclosan increases methylation ISO RGD:736916 6480464 Triclosan results in increased methylation of GNAS gene CTD PMID:34523531 triptonide increases expression EXP 6480464 triptonide results in increased expression of GNAS mRNA CTD PMID:33045310 tunicamycin decreases expression EXP 6480464 Tunicamycin results in decreased expression of GNAS mRNA CTD PMID:17127020 U-73122 multiple interactions EXP 6480464 1-(6-((3-methoxyestra-1 more ... CTD PMID:23022524 valproic acid affects expression EXP 6480464 Valproic Acid affects the expression of GNAS mRNA CTD PMID:17292431 valproic acid multiple interactions ISO RGD:736916 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GNAS mRNA CTD PMID:27188386 valproic acid increases expression ISO RGD:736916 6480464 Valproic Acid results in increased expression of GNAS mRNA CTD PMID:24383497 more ... valproic acid affects expression ISO RGD:736916 6480464 Valproic Acid affects the expression of GNAS mRNA CTD PMID:23179753 vitamin E multiple interactions ISO RGD:736916 6480464 [Selenium co-treated with Vitamin E] results in decreased expression of GNAS mRNA CTD PMID:19244175 vorinostat decreases expression ISO RGD:736916 6480464 vorinostat results in decreased expression of GNAS mRNA CTD PMID:27188386 zinc sulfate decreases activity ISO RGD:2716 6480464 Zinc Sulfate results in decreased activity of GNAS protein CTD PMID:15546818